- Home
- ELAN vs ARCC Comparison
ELAN vs ARCC Comparison
Compare ELAN & ARCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELAN | ARCC |
|---|---|---|
| Founded | 1954 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 13.6B |
| IPO Year | 2018 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ELAN | ARCC |
|---|---|---|
| Price | $23.91 | $17.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $27.89 | $21.36 |
| AVG Volume (30 Days) | 4.9M | ★ 5.0M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 10.28% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.11 | ★ 0.13 |
| Revenue | ★ $4,715,000,000.00 | N/A |
| Revenue This Year | $8.21 | $5.77 |
| Revenue Next Year | $5.31 | $2.29 |
| P/E Ratio | $220.09 | ★ $138.69 |
| Revenue Growth | ★ 6.22 | N/A |
| 52 Week Low | $13.23 | $17.40 |
| 52 Week High | $27.72 | $23.42 |
Technical Indicators
Market Signals| Indicator | ELAN | ARCC |
|---|---|---|
| Relative Strength Index (RSI) | 53.13 | 32.81 |
| Support Level | $23.72 | $17.49 |
| Resistance Level | $24.06 | $19.36 |
| Average True Range (ATR) | 1.04 | 0.30 |
| MACD | -0.00 | -0.12 |
| Stochastic Oscillator | 34.15 | 0.36 |
Price Performance
Historical ComparisonAbout ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
About ARCC Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.